Association of clinical signs and symptoms of Ebola viral disease with case fatality: a systematic review and meta-analysis

References

• Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, etal. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014 Oct; 371(15): 1418–25.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Ebola Response Team. Ebola virus disease in West Africa – The first 9 months of the epidemic and forward projections. N Engl J Med. 2014 Oct; 371(16): 1481–95.
   Web of Science ®Google Scholar
• World Health Organization. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ. 1978; 56(2): 247–70.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ebola haemorrhagic fever in Zaire, 1976. Report of an International Convention. Bull World Health Organ. 1978; 56(2): 271–93.
   PubMed Web of Science ®Google Scholar
• Goeijenbier M, van Kampen JJ, Reusken CB, Koopmans MP, van Gorp EC. Ebola virus disease: A review on epidemiology, symptoms, treatment and pathogenesis. Neth J Med. 2014; 72(9): 442–8.
   PubMed Web of Science ®Google Scholar
• Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011; 377(9768): 849–62.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Ebola virus disease information for clinicians in U.S. healthcare settings. 2014. Available from: www.cdc.gov/vhf/ebola/hcp/clinician-information-us-healthcare-settings.html [cited 19 November 2014].
   Google Scholar
• Schieffelin SJ, Shaffer GJ, Goba A, Gbakie M, Gire SK, Colubri A, etal. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014 Nov; 371(22): 2092–100.
   PubMed Web of Science ®Google Scholar
• Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007 Nov; 196(Suppl 2): S364–71.
   PubMed Web of Science ®Google Scholar
• Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. Br Med J. 1992; 304: 1491–4.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, etal. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 1996; 17: 1–12.
   PubMedGoogle Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, etal. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15): 2008–12.
   PubMed Web of Science ®Google Scholar
• Stuart A, Ord JK. Kendall's advanced theory of statistics. 1994; 6th edn, London: Edward Arnold.
   Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177–88.
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Egger M, Smith GD, Altman DG. Systematic reviews of evaluations of diagnostic and screening tests. Systematic reviews in health care. Meta-analysis in context . 2001; London: BMJ Books. 157–62.
   Google Scholar
• Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2005; 25(20): 3443–57.
   Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088–101.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Egger M, Davey-Smith G. Investigating and dealing with publication and other biases in meta-analysis. Br Med J. 2001; 323: 101–5.
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol. 2001; 54: 1046–55.
   PubMed Web of Science ®Google Scholar
• Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, etal. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med. 2015; 372: 40–7.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001–July 2002. Wkly Epidemiol Rec. 2003; 78(26): 223–5.
   Google Scholar
• Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, etal. An outbreak of Ebola in Uganda. Trop Med Int Health. 2002; 7(12): 1068–75.
   PubMed Web of Science ®Google Scholar
• Georges AJ, Leroy EM, Renaud AA, Benissan CT, Nabias RJ, Ngoc MT, etal. Ebola hemorrhagic fever outbreaks in Gabon, 1994–1997: Epidemiologic and health control issues. J Infect Dis. 1999; 179: S65–75.
   PubMed Web of Science ®Google Scholar
• Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns AS, etal. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis. 1999; 179: S76–86.
   PubMed Web of Science ®Google Scholar
• Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011; 204(Suppl 3): S810–16.
   PubMed Web of Science ®Google Scholar
• Jeffs B. A clinical guide to viral hemorrhagic fevers: Ebola, Marburg and Lassa. Trop Doct. 2006; 36(1): 1–4.
   PubMed Web of Science ®Google Scholar
• Baize S, Leroy EM, Georges AJ, Georges-Courbot MC, Capron M, Bedjabaga I, etal. Inflammatory responses in Ebola virus infected patients. Clin Exp Immunol. 2002; 128(1): 163–8.
   Web of Science ®Google Scholar
• Leroy EM, Baize S, Debre P, Lansoud-Soukate J, Mavoungou E. Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol. 2001; 124(3): 453–60.
   PubMed Web of Science ®Google Scholar